Making Cancer History® Seminar returns to Aspen Meadows Resort
MD Anderson experts to discuss Moon Shots Program, historic initiative to conquer cancer
MD Anderson News Release 06/24/13
The University of Texas MD Anderson Cancer Center plans its 15th annual Making Cancer History® Seminar in Aspen, 1-3 p.m. July 16. The free event is at Aspen Meadows Resort’s Paepcke Auditorium, 1000 N. Third St. Seating is limited. See registration information below.
This year’s seminar...
‘Emperor of All Maladies’ Author Headlines Cancer Survivorship Conference Sept. 27-28
2011 Pulitzer Prize winner to discuss his ‘biography’ of the disease with patients, survivors
MD Anderson News Release...
Children's Cancer Hospital Opens New Combination Inpatient and Outpatient Unit
New and unique space consolidates pediatric treatment services on one floor with patient amenities
MD Anderson News Release...
Ibrutinib continues strong showing against mantle cell lymphoma
Latest results of Phase 2 study confirm high rate of response, remission
MD Anderson News Release 06-19-13
In a major international study led by researchers at The University of Texas MD Anderson Cancer Center, the targeted therapy ibrutinib continues to show remarkable promise for the treatment of relapsed or refractory mantle cell lymphoma (MCL).
The most recent interim findings of the 18-center Phase...
Scientists catch EGFR passing a crucial message to cancer-promoting protein
Signal tells MCM7 to launch DNA replication; pathway reduces breast cancer patient survival
MD Anderson News Release 06...
Infographic: How to fill a healthy barbecue plate
MD Anderson experts offer tips for healthier grilling
MD Anderson News Release 06/11/13
Adults can avoid cancer-causing...
Cooper University Health Care and MD Anderson Cancer Center Announce Partnership
MD Anderson News Release 06/10/13
CAMDEN, NJ – Cooper University Health Care and MD Anderson Cancer Center have signed a letter of intent...
MET protein levels show promise as biomarker for aggressive colon cancer
Correlation of protein phenotype brings researchers one step closer to personalized cancer treatment
MD Anderson News...
Test helps target glioblastoma patients most likely to benefit from bevacizumab
Gene panel may help personalize therapy for aggressive brain tumors
MD Anderson News Release 06/02/13
Abstract...
Bevacizumab offers no benefit for newly diagnosed glioblastoma, MD Anderson-led study finds
MD Anderson News Release 06/02/13
ABSTRACT 1
The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival...